Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better.
Loria F, Mone P, Rispoli A, Di Fonzo R, Masarone D, Mancusi C, Correale M, Vitullo A, Granatiero M, Mazzeo P, Mercurio V, Fiore F, Di Sarro E, Falco L, Izzo C, Campanile A, Virtuoso N, Stabile E, Bonanno S, Dattilo G, Tocchetti CG, Santulli G, Vecchione C, Ciccarelli M, Visco V. Loria F, et al. Among authors: masarone d. Cardiovasc Diabetol. 2024 Nov 22;23(1):423. doi: 10.1186/s12933-024-02515-5. Cardiovasc Diabetol. 2024. PMID: 39578847 Free PMC article.
Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry.
Kaski JP, Norrish G, Gimeno Blanes JR, Charron P, Elliott P, Tavazzi L, Tendera M, Laroche C, Maggioni AP, Baban A, Khraiche D, Ziolkowska L, Limongelli G, Ojala T, Gorenflo M, Anastasakis A, Mostafa S, Caforio ALP; EORP Paediatric Cardiomyopathy Registry Investigators. Kaski JP, et al. Eur Heart J. 2024 Apr 21;45(16):1443-1454. doi: 10.1093/eurheartj/ehae109. Eur Heart J. 2024. PMID: 38427064 Free PMC article.
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry.
Inciardi RM, Vaduganathan M, Lombardi CM, Gussago C, Agostoni P, Ameri P, Aspromonte N, Calò L, Cameli M, Carluccio E, Carugo S, Cipriani M, De Caterina R, De Ferrari GM, Emdin M, Fornaro A, Guazzi M, Iacoviello M, Imazio M, La Rovere MT, Leonardi S, Maccallini M, Masarone D, Moschini L, Palazzuoli A, Patti G, Pedretti RFE, Perrone Filardi P, Piepoli MF, Potena L, Salzano A, Sciacqua A, Senni M, Sinagra G, Specchia C, Taddei S, Vizza D, Savarese G, Rosano G, Volterrani M, Metra M;  on behalf of the OPTIPHARM‐HF Investigators. Inciardi RM, et al. Among authors: masarone d. Eur J Heart Fail. 2024 Aug;26(8):1707-1714. doi: 10.1002/ejhf.3260. Epub 2024 Jun 23. Eur J Heart Fail. 2024. PMID: 38923140 Free article.
106 results